The prevalence of peripheral neuropathy severe enough to cause a loss of protective sensation in a population-based sample of people with known and newly detected diabetes in Barbados: a cross-sectional study

被引:12
作者
Adams, O. P. [1 ]
Herbert, J. R. [1 ]
Howitt, C. [2 ]
Unwin, N. [2 ,3 ]
机构
[1] Univ West Indies, Fac Med Sci, Cave Hill Campus, Wanstead, Barbados
[2] Univ West Indies, George Alleyne Chron Dis Res Ctr, Wanstead, Barbados
[3] Univ Cambridge, MRC Epidemiol Unit, Cambridge, England
关键词
FOOT ULCERS; RISK; COMPLICATIONS; PREVENTION; AMPUTATIONS; MULTICENTER; MANAGEMENT; DISEASE; COST;
D O I
10.1111/dme.13989
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Aims To determine the prevalence and potential risk factors for diabetic peripheral neuropathy with a loss of protective sensation in Barbados. Methods A representative population sample aged > 25 years with previously diagnosed diabetes or a fasting blood glucose >= 7 mmol/l or HbA(1c) >= 48 mmol/mol (6.5%) was tested by 10 g monofilament at four plantar sites per foot and a 28 Hz tuning fork and neurothesiometer at the hallux. Data were adjusted to the age structure of people with diabetes in Barbados. Multivariable logistic regression assessed associations with peripheral neuropathy with a loss of protective sensation. Results Of 236 participants [74% response rate, 33% men, 91% black, median age 58.6 years, mean BMI 30.1 kg/m(2), mean HbA(1c) 54 mmol/mol (7.1%)], 51% had previously diagnosed diabetes. Foot examination demonstrated that 25.8% (95% CI 20.2 to 31.5) had at least one insensate site with monofilament testing, 14.8% (95% CI 10.2 to 19.4) had an abnormal tuning fork test and 10.9% (95% CI 6.9 to 14.9) had a vibration perception threshold > 25 V. Peripheral neuropathy with a loss of protective sensation prevalence was 28.5% (95% CI 22.7 to 34.4) as indicated by monofilament with >= 1 insensate site and/or vibration perception threshold > 25 V. With previously diagnosed diabetes the prevalence was 36.4% (95% CI 27.7 to 45.2) with 98.4% of cases identified by monofilament testing. Increasing age, previously diagnosed diabetes, male sex and abdominal obesity were independently associated with peripheral neuropathy with a loss of protective sensation. Conclusions Over a third of people with previously diagnosed diabetes had evidence of peripheral neuropathy with a loss of protective sensation. Monofilament testing alone may be adequate to rule out peripheral neuropathy with a loss of protective sensation. Monofilament and neurothesiometer stimuli are reproducible but dependent on participant response.
引用
收藏
页码:1629 / 1636
页数:8
相关论文
共 34 条
[1]   Are primary care practitioners in Barbados following diabetes guidelines? - A chart audit with comparison between public and private care sectors [J].
Adams O.P. ;
Carter A. .
BMC Research Notes, 4 (1)
[2]   Risk factors for diabetic peripheral sensory neuropathy - Results of the Seattle Prospective Diabetic Foot Study [J].
Adler, AI ;
Boyko, EJ ;
Ahroni, JH ;
Stensel, V ;
Forsberg, RC ;
Smith, DG .
DIABETES CARE, 1997, 20 (07) :1162-1167
[3]  
[Anonymous], 2019, DIABETES CARE, V42, pS124
[4]  
Barbados National Drug Formulary, 2014, BARB NAT DRUG FORM
[5]   Differences in the performance of commercially available 10-g monofilaments [J].
Booth, J ;
Young, MJ .
DIABETES CARE, 2000, 23 (07) :984-988
[6]  
Boulton AJM, 2008, DIABETES CARE, V31, P1679, DOI 10.2337/dc08-9021
[7]   Introduction [J].
Cheng, Alice Y. Y. .
CANADIAN JOURNAL OF DIABETES, 2013, 37 :S1-S3
[8]  
CHRC/PAHO, 2006, MAN DIAB PRIM CAR CA
[9]   Explanations for the high risk of diabetes-related amputation in a Caribbean population of black African descent and potential for prevention [J].
Hennis, AJM ;
Fraser, HS ;
Jonnalagadda, R ;
Fuller, J ;
Chaturvedi, N .
DIABETES CARE, 2004, 27 (11) :2636-2641
[10]   Use of the Michigan Neuropathy Screening Instrument as a measure of distal symmetrical peripheral neuropathy in Type 1 diabetes: results from the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications [J].
Herman, W. H. ;
Pop-Busui, R. ;
Braffett, B. H. ;
Martin, C. L. ;
Cleary, P. A. ;
Albers, J. W. ;
Feldman, E. L. .
DIABETIC MEDICINE, 2012, 29 (07) :937-944